-
1
-
-
9544249708
-
Desipramine Pharmacokinetics with the Serotonin Reuptake Inhibitors, Paroxetine or Sertraline
-
Abstract presented 26 June to 1 July, Washington
-
ALDERMAN, J., GREENBLATT, D. J., ALLISON, J., PRESKORN, S. H., CHUNG, M. AND HARRISON, W.: Desipramine Pharmacokinetics with the Serotonin Reuptake Inhibitors, Paroxetine or Sertraline, Abstract presented at the XIX CINP Congress, 26 June to 1 July, Washington, 1994.
-
(1994)
XIX CINP Congress
-
-
Alderman, J.1
Greenblatt, D.J.2
Allison, J.3
Preskorn, S.H.4
Chung, M.5
Harrison, W.6
-
2
-
-
0024309378
-
Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxyeoumarin by human liver microsomes in vitro
-
BACK, D. J., STEVENSON, P. AND TJIA, J. F.: Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxyeoumarin by human liver microsomes in vitro. Br. J. Clin. Pharmacol. 28: 166-170, 1989.
-
(1989)
Br. J. Clin. Pharmacol.
, vol.28
, pp. 166-170
-
-
Back, D.J.1
Stevenson, P.2
Tjia, J.F.3
-
3
-
-
0027155665
-
Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of naringin
-
BAILEY, D. G., ARNOLD, J. M. O., MUNOZ, C. AND SPENCE, J. D.: Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of naringin. Clin. Pharmacol. Ther. 53: 637-642, 1993.
-
(1993)
Clin. Pharmacol. Ther.
, vol.53
, pp. 637-642
-
-
Bailey, D.G.1
Arnold, J.M.O.2
Munoz, C.3
Spence, J.D.4
-
4
-
-
0022898438
-
Importance of oxidative polymorphisms and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites
-
BALANT-GORGIA, A. E., BALANT, L. P., GENET, C. H., DAYER, P., AESCHLIMANN, J. M. AND GARRONNE, G.: Importance of oxidative polymorphisms and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites. Eur. J. Clin. Pharmacol. 31: 449-455, 1986.
-
(1986)
Eur. J. Clin. Pharmacol.
, vol.31
, pp. 449-455
-
-
Balant-Gorgia, A.E.1
Balant, L.P.2
Genet, C.H.3
Dayer, P.4
Aeschlimann, J.M.5
Garronne, G.6
-
5
-
-
0029671175
-
Human cytochromes P450 expressed in E. Coli: Production of specific antibodies
-
BELLOC, C., BAIRD, S., COSME, J., LECOEUR, S., GAUTIER, J.-C., CHALLINE, D., DE WAZIERS, I., FLINOIS, J.-P. AND BEAUNE, P.: Human cytochromes P450 expressed in E. Coli: Production of specific antibodies. Toxicology 106: 207-219, 1996.
-
(1996)
Toxicology
, vol.106
, pp. 207-219
-
-
Belloc, C.1
Baird, S.2
Cosme, J.3
Lecoeur, S.4
Gautier, J.-C.5
Challine, D.6
De Waziers, I.7
Flinois, J.-P.8
Beaune, P.9
-
6
-
-
0026019728
-
Fluvoxaminetricyclic antidepressant interaction
-
BERTSCHY, G., VANDEL, S., VANDEL, B., ALLERS, G. AND VOLMAT, R.: Fluvoxaminetricyclic antidepressant interaction. Eur. J. Clin. Pharmacol. 40: 119-120, 1991.
-
(1991)
Eur. J. Clin. Pharmacol.
, vol.40
, pp. 119-120
-
-
Bertschy, G.1
Vandel, S.2
Vandel, B.3
Allers, G.4
Volmat, R.5
-
7
-
-
0026469799
-
Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes
-
BREYER-PFAFF, U., PFANDL, B., NILL, K., NASSER, E., MONNEY, C., JONZIER-PEREY, M., BAETTIG, D. AND BAUMANN, P.: Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes. Clin. Pharmacol. Ther. 52: 350-358, 1992.
-
(1992)
Clin. Pharmacol. Ther.
, vol.52
, pp. 350-358
-
-
Breyer-Pfaff, U.1
Pfandl, B.2
Nill, K.3
Nasser, E.4
Monney, C.5
Jonzier-Perey, M.6
Baettig, D.7
Baumann, P.8
-
8
-
-
0024359574
-
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
-
BRØSEN, K. AND GRAM, L. F.: Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur. J. Clin. Pharmacol. 36: 537-547, 1989.
-
(1989)
Eur. J. Clin. Pharmacol.
, vol.36
, pp. 537-547
-
-
Brøsen, K.1
Gram, L.F.2
-
9
-
-
0025829102
-
Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine and mephenytoin
-
BRØSEN, K., GRAM, L. F. AND KRAGH-SØRENSEN, P.: Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine and mephenytoin. Ther. Drug Monit. 13: 177-182, 1991a.
-
(1991)
Ther. Drug Monit.
, vol.13
, pp. 177-182
-
-
Brøsen, K.1
Gram, L.F.2
Kragh-Sørensen, P.3
-
10
-
-
0027167470
-
Inhibition of paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine
-
BRØSEN, K., HANSEN, M. J. G., KRAMER NIELSEN, K., SINDRUP, S. H. AND GRAM, L. F.: Inhibition of paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine. Eur. J. Clin. Pharmacol. 44: 349-355, 1993a.
-
(1993)
Eur. J. Clin. Pharmacol.
, vol.44
, pp. 349-355
-
-
Brøsen, K.1
Hansen, M.J.G.2
Kramer Nielsen, K.3
Sindrup, S.H.4
Gram, L.F.5
-
11
-
-
0023032092
-
Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype
-
BRØSEN, K., OTTON, S. V. AND GRAM, L. F.: Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype. Clin. Pharmacol. Ther. 40: 543-549, 1986.
-
(1986)
Clin. Pharmacol. Ther.
, vol.40
, pp. 543-549
-
-
Brøsen, K.1
Otton, S.V.2
Gram, L.F.3
-
12
-
-
0027406654
-
Fluvoxamine is a potent inhibitor of cytochrome P4501A2
-
BRØSEN, K., SKJELBO, E., RASMUSSEN, B. B., POULSEN, H. E. AND LOFT, S.: Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem. Pharmacol. 45: 1211-1214, 1993b.
-
(1993)
Biochem. Pharmacol.
, vol.45
, pp. 1211-1214
-
-
Brøsen, K.1
Skjelbo, E.2
Rasmussen, B.B.3
Poulsen, H.E.4
Loft, S.5
-
13
-
-
0025733250
-
Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine
-
BRØSEN, K., ZEUGIN, T. AND MEYER, U. A.: Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clin. Pharmacol. Ther. 49: 609-617, 1991b.
-
(1991)
Clin. Pharmacol. Ther.
, vol.49
, pp. 609-617
-
-
Brøsen, K.1
Zeugin, T.2
Meyer, U.A.3
-
14
-
-
0026787192
-
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes
-
CREWE, H. K., LENNARD, M. S., TUCKER, G. T., WOODS, F. R. AND HADDOCK, R. E.: The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br. J. Clin. Pharmacol. 34: 262-265, 1992.
-
(1992)
Br. J. Clin. Pharmacol.
, vol.34
, pp. 262-265
-
-
Crewe, H.K.1
Lennard, M.S.2
Tucker, G.T.3
Woods, F.R.4
Haddock, R.E.5
-
15
-
-
0028279041
-
Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans
-
GOLDSTEIN, J. A., FALETTO, M. B., ROMKES-SPARKS, M., KITAREEWAN, S., RAUCHY, J. L., LASKER, J. M. AND GHANAYEM, B. I.: Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 33: 1743-1752, 1994.
-
(1994)
Biochemistry
, vol.33
, pp. 1743-1752
-
-
Goldstein, J.A.1
Faletto, M.B.2
Romkes-Sparks, M.3
Kitareewan, S.4
Rauchy, J.L.5
Lasker, J.M.6
Ghanayem, B.I.7
-
16
-
-
12644288620
-
Influence du sexe et du tabagisme sur les concentrations plasmatiques de la clomipramine, de l'amitriptyline et de leurs métabolites déméthylés
-
GOUEZO, F., ROP, P. P. AND VIALA, A.: Influence du sexe et du tabagisme sur les concentrations plasmatiques de la clomipramine, de l'amitriptyline et de leurs métabolites déméthylés. J. Toxicol. Clin. Exp. 8: 39-46, 1988.
-
(1988)
J. Toxicol. Clin. Exp.
, vol.8
, pp. 39-46
-
-
Gouezo, F.1
Rop, P.P.2
Viala, A.3
-
17
-
-
0025757011
-
Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples
-
GUENGERICH, F. P. ANND TURVEY, C. G.: Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256: 1189-1194, 1990.
-
(1990)
J. Pharmacol. Exp. Ther.
, vol.256
, pp. 1189-1194
-
-
Guengerich, F.P.1
Turvey, C.G.2
-
18
-
-
0027401927
-
Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients
-
HÄRTTER, S., WETZEL, H., HAMMES, E. AND HIEMKE, C.: Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology 110: 302-308, 1993.
-
(1993)
Psychopharmacology
, vol.110
, pp. 302-308
-
-
Härtter, S.1
Wetzel, H.2
Hammes, E.3
Hiemke, C.4
-
20
-
-
0019185720
-
Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing
-
JOHN, V. A., LUSCOMBE, D. K. AND KEMP, H.: Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing. J. Int. Med. Res. 8: 88-95, 1980.
-
(1980)
J. Int. Med. Res.
, vol.8
, pp. 88-95
-
-
John, V.A.1
Luscombe, D.K.2
Kemp, H.3
-
21
-
-
0027538491
-
High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine
-
KRAMER NIELSEN, K. AND BRØSEN, K.: High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine. Ther. Drug Monit. 15: 122-128, 1993.
-
(1993)
Ther. Drug Monit.
, vol.15
, pp. 122-128
-
-
Kramer Nielsen, K.1
Brøsen, K.2
-
22
-
-
0026739661
-
Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism
-
KRAMER NIELSEN, K., BRØSEN, K., GRAM, L. F. AND DANISH UNIVERSITY ANTIDEPRESSANT GROUP: Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism. Eur. J. Clin. Pharmacol. 43: 405-411, 1992.
-
(1992)
Eur. J. Clin. Pharmacol.
, vol.43
, pp. 405-411
-
-
Kramer Nielsen, K.1
Brøsen, K.2
Gram, L.F.3
-
23
-
-
0028303496
-
Single-dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms
-
KRAMER NIELSEN, K., BRØSEN, K., HANSEN, M. G. J. AND GRAM, L. F.: Single-dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms. Clin. Pharmacol. Ther. 55: 518-527, 1994a.
-
(1994)
Clin. Pharmacol. Ther.
, vol.55
, pp. 518-527
-
-
Kramer Nielsen, K.1
Brøsen, K.2
Hansen, M.G.J.3
Gram, L.F.4
-
24
-
-
0028044040
-
Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype
-
KRAMER NIELSEN, K., BRØSEN, K., HANSEN, M. G. J. AND GRAM, L. F.: Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype. Eur. J. Clin. Pharmacol. 47: 209-210, 1994b.
-
(1994)
Eur. J. Clin. Pharmacol.
, vol.47
, pp. 209-210
-
-
Kramer Nielsen, K.1
Brøsen, K.2
Hansen, M.G.J.3
Gram, L.F.4
-
25
-
-
0019618129
-
Cytochrome P450 monooxygenase activities in human and rat liver microsomes
-
KREMERS, P., BEAUNE, P., CRESTEIL, T., DEGRAEVE, J., COLUMELLI, S., LEROUX, J. P. AND GIELEN, J.: Cytochrome P450 monooxygenase activities in human and rat liver microsomes. Eur. J. Biochem. 118: 599-606, 1981.
-
(1981)
Eur. J. Biochem.
, vol.118
, pp. 599-606
-
-
Kremers, P.1
Beaune, P.2
Cresteil, T.3
Degraeve, J.4
Columelli, S.5
Leroux, J.P.6
Gielen, J.7
-
26
-
-
0027230584
-
Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver
-
LEMOINE, A., GAUTIER, J. C., AZOULAY, D., KIFFEL, L., BELLOC, C., GUENGERICH, F. P., MAUREL, P., BEAUNE, P. AND LEBOUX, J. P.: Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Mol. Pharmacol. 43: 827-832, 1993.
-
(1993)
Mol. Pharmacol.
, vol.43
, pp. 827-832
-
-
Lemoine, A.1
Gautier, J.C.2
Azoulay, D.3
Kiffel, L.4
Belloc, C.5
Guengerich, F.P.6
Maurel, P.7
Beaune, P.8
Leboux, J.P.9
-
27
-
-
71849104860
-
Protein measurement with the Folin phenol reagent
-
LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
-
(1951)
J. Biol. Chem.
, vol.193
, pp. 265-275
-
-
Lowry, O.H.1
Rosebrough, N.J.2
Farr, A.L.3
Randall, R.J.4
-
28
-
-
0020635141
-
Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation
-
MEIER, P. J., MUELLER, H. K., DICK, B. AND MEYER, U. A.: Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. Gastroenterology 85: 682-692, 1983.
-
(1983)
Gastroenterology
, vol.85
, pp. 682-692
-
-
Meier, P.J.1
Mueller, H.K.2
Dick, B.3
Meyer, U.A.4
-
29
-
-
0027477751
-
A potentially hazardous interaction between erythromycin and midazolam
-
OLKKOLA, K. T., ARANKO, K., LUURILA, H., HILLER, A., SAARNIVAARA, L., HIMBERG, J. J. AND NEUVONEN, P. J.: A potentially hazardous interaction between erythromycin and midazolam. Clin. Pharmacol. Ther. 53: 298-305, 1993.
-
(1993)
Clin. Pharmacol. Ther.
, vol.53
, pp. 298-305
-
-
Olkkola, K.T.1
Aranko, K.2
Luurila, H.3
Hiller, A.4
Saarnivaara, L.5
Himberg, J.J.6
Neuvonen, P.J.7
-
30
-
-
0027456438
-
Inhibition by fluoxetine of cytochrome P4502D6 activity
-
OTTON, S. V., DAFAN, W., JOFFE, R. T., CHEAVY, S. W. AND SELLERS, E. M.: Inhibition by fluoxetine of cytochrome P4502D6 activity. Clin. Pharmacol. Ther. 53: 401-409, 1993.
-
(1993)
Clin. Pharmacol. Ther.
, vol.53
, pp. 401-409
-
-
Otton, S.V.1
Dafan, W.2
Joffe, R.T.3
Cheavy, S.W.4
Sellers, E.M.5
-
31
-
-
0021345446
-
Competitive inhibition of sparteine oxidation in human liver beta adrenoceptor antagonists and other cardiovascular drugs
-
OTTON, S. V., INABA, T. AND KALOW, W.: Competitive inhibition of sparteine oxidation in human liver beta adrenoceptor antagonists and other cardiovascular drugs. Life Sci. 34: 73-80, 1984.
-
(1984)
Life Sci.
, vol.34
, pp. 73-80
-
-
Otton, S.V.1
Inaba, T.2
Kalow, W.3
-
32
-
-
0028348762
-
Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine
-
PRESKORN, S. H., ALDERMAN, J., CHUNG, M., HARRISON, W., MESSIG, M. AND HARRIS, S.: Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J. Clin. Pharmacol. 14: 90-98, 1994.
-
(1994)
J. Clin. Pharmacol.
, vol.14
, pp. 90-98
-
-
Preskorn, S.H.1
Alderman, J.2
Chung, M.3
Harrison, W.4
Messig, M.5
Harris, S.6
-
33
-
-
0028898044
-
Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: Potent inhibition by fluvoxamine
-
RASMUSSEN, B. B., MÄENPÄÄ, J., PELKONEN, O., LOFT, S., POULSEN, H. E., LYKKESFELDT, J. AND BRØSEN, K.: Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: Potent inhibition by fluvoxamine. Br. J. Clin. Pharmacol. 39: 151-159, 1995.
-
(1995)
Br. J. Clin. Pharmacol.
, vol.39
, pp. 151-159
-
-
Rasmussen, B.B.1
Mäenpää, J.2
Pelkonen, O.3
Loft, S.4
Poulsen, H.E.5
Lykkesfeldt, J.6
Brøsen, K.7
-
34
-
-
0018633231
-
Clomipramine: Plasma levels and clinical effects
-
REISBY, N., GRAM, L. F., BECH, P., SIHM, F., KRAUTWALD, O., ELLEY, J., ORTMANN, J. AND CHRISTIANSEN, J.: Clomipramine: Plasma levels and clinical effects. Commun. Psychopharmacol. 3: 341-351, 1979.
-
(1979)
Commun. Psychopharmacol.
, vol.3
, pp. 341-351
-
-
Reisby, N.1
Gram, L.F.2
Bech, P.3
Sihm, F.4
Krautwald, O.5
Elley, J.6
Ortmann, J.7
Christiansen, J.8
-
35
-
-
0025670512
-
Expression of human liver cytochrome P-450IIIA in yeast: A functional model for the hepatic enzyme
-
RENAUD, J. P., CULLIN, C., POMPON, P., BEAUNE, P. AND MANSUY, D.: Expression of human liver cytochrome P-450IIIA in yeast: A functional model for the hepatic enzyme. Eur. J. Biochem. 194: 889-896, 1990.
-
(1990)
Eur. J. Biochem.
, vol.194
, pp. 889-896
-
-
Renaud, J.P.1
Cullin, C.2
Pompon, P.3
Beaune, P.4
Mansuy, D.5
-
36
-
-
0023687412
-
A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking
-
SESARDIC, D., BOOBIS, A. R., EDWARDS, R. J. AND DAVIES, D. S.: A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26: 363-372, 1988.
-
(1988)
Br. J. Clin. Pharmacol.
, vol.26
, pp. 363-372
-
-
Sesardic, D.1
Boobis, A.R.2
Edwards, R.J.3
Davies, D.S.4
-
37
-
-
0028237729
-
Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidations of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 caucasians
-
SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. AND GUENGERICH, F. P.: Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidations of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 caucasians. J. Pharmacol. Exp. Ther. 270: 414-423, 1994.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.270
, pp. 414-423
-
-
Shimada, T.1
Yamazaki, H.2
Mimura, M.3
Inui, Y.4
Guengerich, F.P.5
-
38
-
-
0025076711
-
Non-linear kinetics of imipramine in low and medium plasma level ranges
-
SINDRUP, S. H., BRØSEN, K. AND GRAM, L. F.: Non-linear kinetics of imipramine in low and medium plasma level ranges. Ther. Drug Monit. 12: 445-449, 1990.
-
(1990)
Ther. Drug Monit.
, vol.12
, pp. 445-449
-
-
Sindrup, S.H.1
Brøsen, K.2
Gram, L.F.3
-
39
-
-
0027472058
-
Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphism
-
SINDRUP, S. H., BRØSEN, K., HANSEN, M. G. J., AAES-JØRGENSEN, T., OVERØ, K. F. AND GRAM, L. F.: Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphism. Ther. Drug Monit. 15: 11-17, 1993.
-
(1993)
Ther. Drug Monit.
, vol.15
, pp. 11-17
-
-
Sindrup, S.H.1
Brøsen, K.2
Hansen, M.G.J.3
Aaes-Jørgensen, T.4
Overø, K.F.5
Gram, L.F.6
-
40
-
-
0026795695
-
Inhibitors of imipramine metabolism by human liver microsomes
-
SKJELBO, E. AND BRØSEN, K.: Inhibitors of imipramine metabolism by human liver microsomes. Br. J. Clin. Pharmacol. 34: 256-261, 1992.
-
(1992)
Br. J. Clin. Pharmacol.
, vol.34
, pp. 256-261
-
-
Skjelbo, E.1
Brøsen, K.2
-
41
-
-
0025964524
-
The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine
-
SKJELBO, E., BRØSEN, K., HALLAS, J. AND GRAM, L. F.: The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine. Clin. Pharmacol. Ther. 49: 18-23, 1991.
-
(1991)
Clin. Pharmacol. Ther.
, vol.49
, pp. 18-23
-
-
Skjelbo, E.1
Brøsen, K.2
Hallas, J.3
Gram, L.F.4
-
42
-
-
0027254118
-
Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects
-
SPINA, E., POLLICINO, A. M., AVENOSO, A., CAMPO, G. M., PERUCCA, E. AND CAPUTI, A. P.: Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Ther. Drug Monit. 15: 243-246, 1993.
-
(1993)
Ther. Drug Monit.
, vol.15
, pp. 243-246
-
-
Spina, E.1
Pollicino, A.M.2
Avenoso, A.3
Campo, G.M.4
Perucca, E.5
Caputi, A.P.6
-
43
-
-
0022979770
-
Inhibitory effects of neuroleptics on debrisoquine oxidation in man
-
SYVÄLAHTI, E. K. G., LINDBERG, R., KALLIO, J. AND DE VOCHT, M.: Inhibitory effects of neuroleptics on debrisoquine oxidation in man. Br. J. Clin. Pharmacol. 22: 89-92, 1986.
-
(1986)
Br. J. Clin. Pharmacol.
, vol.22
, pp. 89-92
-
-
Syvälahti, E.K.G.1
Lindberg, R.2
Kallio, J.3
De Vocht, M.4
-
44
-
-
0020080162
-
Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response
-
VANDEL, B., VANDEL, S., JOUNET, J. M., ALLERS, G. AND VOLMAT, R.: Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response. Eur. J. Clin. Pharmacol. 22: 15-20, 1982.
-
(1982)
Eur. J. Clin. Pharmacol.
, vol.22
, pp. 15-20
-
-
Vandel, B.1
Vandel, S.2
Jounet, J.M.3
Allers, G.4
Volmat, R.5
-
45
-
-
0027445449
-
Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation
-
WRIGHTON, S. A., STEVENS, J. C., BECKER, G. W. AND VANDENBRANDEN, M.: Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Arch. Biochem. Biophys. 306: 240-245, 1993.
-
(1993)
Arch. Biochem. Biophys.
, vol.306
, pp. 240-245
-
-
Wrighton, S.A.1
Stevens, J.C.2
Becker, G.W.3
Vandenbranden, M.4
|